🔗 Permalink

Inventor profile of:

Leah E. Appel

City:

Bend, Oregon

Country:

United States

Published Applications:

Last publication date:

2026-03-19

Top Assignees for applications by Leah E. Appel

The entities that hold a legal rights for patent applications filed by inventor Appel Leah E.:

BEND RESEARCH, INC. 5 Bend, OR United States
PFIZER INC. 4 New York, NY United States
Acer Therapeutics, Inc. 3 Newton, MA United States
PFIZER INC. 1 Groton, CT United States
Ben Research, Inc. 1 Bend, OR United States

Recent patent applications by Appel Leah E.

Leah E. Appel from Bend, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19

US20260076927A1

Human necessities

PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF

#2 | 2024-10-17

US20240342104A1

Human necessities

DOSAGE FORM FOR IMPROVING PALATABILITY OF DRUG SUBSTANCE

#3 | 2023-05-04

US20230133629A1

Human necessities

PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF

#4 | 2021-07-22

US20210220304A1

Human necessities

Methods of treating urea cycle disorders and maple syrup urine disease

#5 | 2021-06-24

US20210186908A1

Human necessities

Palatable compositions including sodium phenylbutyrate and uses thereof

#6 | 2020-08-20

US20200261385A1

Human necessities

Palatable compositions including sodium phenylbutyrate and uses thereof

#7 | 2019-10-10

US20190307702A1

Human necessities

Multiparticulates of spray-coated drug and polymer on a meltable core

#8 | 2017-09-21

US20170266115A1

Human necessities

PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF

#9 | 2015-03-05

US20150064264A1

Human necessities

Pharmaceutical dosage forms comprising a low-solubility drug and a polymer

#10 | 2011-07-28

US20110182947A1

Human necessities

Hydrogel-driven drug dosage form

#11 | 2010-03-18

US20100068276A1

Human necessities

Multiparticulates of spray-coated drug and polymer on a meltable core

#12 | 2009-06-23

US10799536

Controlled release by extrusion of solid amorphous dispersions of drugs

#13 | 2009-06-04

US20090142404A1

Human necessities

PHARMACEUTICAL DOSAGE FORMS COMPRISING A LOW-SOLUBILITY DRUG AND A POLYMER

#14 | 2008-12-25

US20080317851A1

Human necessities

Immediate release dosage forms containing solid drug dispersions

#15 | 2008-12-04

US20080299188A1

Human necessities

CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINTED RELEASE OF LOW-SOLUBILITY DRUG

#16 | 2008-08-21

US20080199527A1

Human necessities

Enteric Coated Azithromycin Multiparticulates

#17 | 2007-04-19

US20070087057A1

Human necessities

Hydrogel-Driven Drug Dosage Form

#18 | 2005-08-25

US20050186285A1

Human necessities

Multiparticulate compositions with improved stability

#19 | 2005-08-18

US20050181062A1

Human necessities

Multiparticulate crystalline drug compositions having controlled release profiles

#20 | 2005-08-18

US20050181061A1

Human necessities

Extrusion process for forming chemically stable drug multiparticulates

#21 | 2005-08-18

US20050181060A1

Human necessities

Method of making pharmaceutical multiparticulates

#22 | 2005-07-21

US20050158391A1

Human necessities

Azithromycin multiparticulate dosage forms by melt-congeal processes

#23 | 2005-07-14

US20050152982A1

Human necessities

Controlled release multiparticulates formed with dissolution enhancers

#24 | 2005-06-09

US20050123616A1

Human necessities

Azithromycin multiparticulate dosage forms by liquid-based processes

InventorID:

1087074 ⎘